AI/ML INNOVATIONS Aktie

 

Agreement positions NeuralCloud's AI-driven cardiac platform for Holter monitoring and ambulatory patient workflow.Partnership introduces CardioYield powered by MaxYield for automated, reliable Hol......

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

Appointment Supports AIML's Commercial Execution and Operational Scale as the Company Advances Its AI-Driven Cardiac PlatformLeadership Addition Aligns Revenue, Delivery, and Product Execution as A......

TORONTO, ON / ACCESS Newswire / December 30, 2025 / AI/ML Innovations Inc. ("AIML" or the "Company") (CSE:AIML)(OTCQB:AIMLF)(FWB:42FB) has announced that its consulting agreement with Campfire Prop......

A Look Back at Key Milestones and Successes Achieved in 2025What's Ahead: Exciting Plans, Strategic Outlook, and Goals for 2026Advancing the Next Phase of Commercialization TORONTO, ON / ACCESS New......

TORONTO, ON / ACCESS Newswire / December 11, 2025 / AI/ML Innovations Inc. (CSE:AIML) ("AIML" or the "Company") is pleased to announce the engagement of Guerilla Capital ("Guerilla"), an arm's leng......

This strengthens NeuralCloud's expansion into the global wellness and B2B health practitioner delivery model with high-fidelity cardiac signal processing and digital health integration.Partnership ......

Early collaboration supports development of Cornerstone's emerging athlete-performance program and extends NeuralCloud's ECG analytics into sports-science and human performance marketsPilot ties Ma......

Agreement expands NeuralCloud's AI-enhanced ECG signal-processing technology into veterinary health and elite equine performance marketsCommercial integration expands MaxYield and CardioYield into ......

Pilot Project to Explore AI-Driven ECG Signal Processing and Predictive Deterioration Models in Pediatric Cardiac Care TORONTO, ON / ACCESS Newswire / November 24, 2025 / NeuralCloud Solutions Inc.......

Patent validates AIML's novel neural-network approach to denoising and mapping ECG signals, powering MaxYield and CardioYield.Reinforces competitive advantage as the Company advances commercializat......

Collaboration Advances Local Regulatory Pathway for AI-Enabled ECG Diagnostics to Address the Growing Cardiovascular Disease Burden in Jamaica TORONTO, ON / ACCESS Newswire / November 4, 2025 / AI/......

NeuralCloud Solutions to deploy its CardioYield platform in a multi-stage pilot program with a full-service cardiology clinic in Canada.Enhance Holter ECG analysis accuracy, efficiency, and workflo......

Toronto, Ontario--(Newsfile Corp. - October 17, 2025) - The following CSE-Listed symbol will become MOC Eligible as detailed below. Symbol Company Name Effective Date AIML AI/ML Innovations Inc. W......

Pilot Study to Lay the Groundwork for Expansion Across JamaicaGoal of the Collaboration is to Demonstrate the Ability to Deliver Affordable, Accurate, and Scalable Holter Diagnostics with CardioYie......

Pilot Evaluation: Toronto Heart Centre to conduct comparative testing of CardioYield for enhanced Holter ECG analysis and reporting efficiency.Clinical Workflow Impact: Study to measure time saving......

TORONTO, Oct. 02, 2025 (GLOBE NEWSWIRE) -- ThreeD Capital Inc., (“ThreeD”) (CSE:IDK / OTCQX:IDKFF) a Canadian based venture capital firm focused on opportunistic investments in companies in the junior resources and disruptive technologies sectors, announces that through the completion of a private placement (the “Acquisition”), ThreeD and Sheldon Inwentash (the “Joint Actor”) acquired ownership and control of an aggregate of 26,000,000 common shares (the “Subject Shares”) and 26,000,000 common share purchase warrants (the “Subject Warrants” and together with the Subject Shares, the “Subject Units”) of AI/ML Innovations Inc. (the “Company” or “AIML”). The Subject Shares represented approximately 10.2% of all issued and outstanding common shares of AIML at the time of the Acquisition (or approximately 18.6% on a partially diluted basis assuming exercise of the Subject Warrants only). Of this total, (i) ThreeD acquired an aggregate of 6,000,000 Subject Shares and 6,000,000 S...

Leveraging MaxYield ECG to capture real-world exercise data in people living with neurological conditionsGenerating actionable insights into how cardiac responses may correlate with brain health an......

VANCOUVER, BC / ACCESS Newswire / September 22, 2025 / AI/ML Innovations Inc. ("AIML" or the "Company") (CSE:AIML)(OTCQB:AIMLF)(FWB:42FB) is pleased to announce that Company completed its previousl......

FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE. THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE: INSTRUMENT NAME KUERZEL/SHORTCODE ISIN AI-ML INNOVATIONS INC. 42FB CA00143Y1034 AB/FROM ONWARDS 04.09.2025 15:02 CET...